scholarly article | Q13442814 |
P2093 | author name string | Bo Liu | |
K Craig Kent | |||
Chunjie Wang | |||
Dai Yamanouchi | |||
Shirling Tsai | |||
Rachel S Edlin | |||
P2860 | cites work | Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization | Q33895700 |
Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathway | Q34331098 | ||
Two major Smad pathways in TGF-beta superfamily signalling. | Q35026971 | ||
Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development | Q35195495 | ||
Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions | Q35607475 | ||
Drug-eluting stents for infrainguinal occlusive disease: progress and challenges | Q36510559 | ||
Pathogen burden, inflammation, proliferation and apoptosis in human in-stent restenosis. Tissue characteristics compared to primary atherosclerosis | Q37866127 | ||
PKCdelta is necessary for Smad3 expression and transforming growth factor beta-induced fibronectin synthesis in vascular smooth muscle cells | Q40318266 | ||
Human in-stent restenosis tissue obtained by means of coronary atherectomy consists of an abundant proteoglycan matrix with a paucity of cell proliferation | Q40629500 | ||
CCR2 deficiency decreases intimal hyperplasia after arterial injury | Q43957593 | ||
The signaling protein Rho is necessary for vascular smooth muscle migration and survival but not for proliferation | Q44130114 | ||
Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition | Q45881572 | ||
The histologic characteristics of primary and restenotic carotid plaque. | Q50524830 | ||
Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. | Q51004193 | ||
Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. | Q51211721 | ||
A proliferation analysis of arterial neointimal hyperplasia: lessons for antiproliferative restenosis therapies. | Q52318787 | ||
Replication in restenotic atherectomy tissue | Q58657458 | ||
Ultrastructural characteristics of human atherectomy tissue from coronary and lower extremity arterial stenoses | Q71076696 | ||
Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy | Q72225398 | ||
Apoptosis in human atherosclerosis and restenosis | Q72256402 | ||
Analysis of atherectomy specimens | Q72541316 | ||
Vascular remodeling. Honey, I think I shrunk the artery | Q72680148 | ||
Differential expression of nonmuscle myosin II isoforms in human atherosclerotic plaque | Q73286960 | ||
Histopathology of in-stent restenosis in patients with peripheral artery disease | Q73303005 | ||
Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries | Q74452823 | ||
Apoptosis in restenosis versus stable-angina atherosclerosis: implications for the pathogenesis of restenosis | Q74794174 | ||
Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth | Q77807906 | ||
The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance | Q78202550 | ||
Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury | Q81575610 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 5 | |
P921 | main subject | atherosclerosis | Q12252367 |
P304 | page(s) | 1289-1295 | |
P577 | publication date | 2009-05-01 | |
P1433 | published in | Journal of Vascular Surgery | Q15755733 |
P1476 | title | Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation | |
P478 | volume | 49 |
Q36679425 | A crosstalk between TGF-β/Smad3 and Wnt/β-catenin pathways promotes vascular smooth muscle cell proliferation |
Q39883888 | Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice |
Q35838998 | Cell division cycle 7 is a novel regulator of transforming growth factor-β-induced smooth muscle cell differentiation |
Q37348858 | Cell division cycle 7 mediates transforming growth factor-β-induced smooth muscle maturation through activation of myocardin gene transcription |
Q42263710 | Distinct gene expression profiles associated with Notch ligands Delta-like 4 and Jagged1 in plaque material from peripheral artery disease patients: a pilot study |
Q50924514 | Effects of Different Simple Triglycerides on Cell Fatty Acid Compositions, Proliferation-Related Protein, and Gene Expressions Induced by Oxidized-LDL in HUVSMCs. |
Q48599185 | Effects of Smad3 on the proliferation and steroidogenesis in human ovarian luteinized granulosa cells |
Q33590493 | Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) mice |
Q38843287 | Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: Implications in the progression of human peripheral artery restenosis |
Q24651685 | Genetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study |
Q34076223 | Halofuginone stimulates adaptive remodeling and preserves re-endothelialization in balloon-injured rat carotid arteries |
Q37420405 | Local CXCR4 Upregulation in the Injured Arterial Wall Contributes to Intimal Hyperplasia |
Q35604813 | MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2. |
Q38401252 | Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study |
Q33814834 | Protein kinase C delta mediates arterial injury responses through regulation of vascular smooth muscle cell apoptosis |
Q34712927 | RCMV increases intimal hyperplasia by inducing inflammation, MCP-1 expression and recruitment of adventitial cells to intima |
Q55479087 | Role of Smad3 signaling in the epithelial‑mesenchymal transition of the lens epithelium following injury. |
Q42426414 | Role of TGF-β1/Smad3 signaling pathway in secretion of type I and III collagen by vascular smooth muscle cells of rats undergoing balloon injury |
Q35095828 | Serum TGF-β1 and SMAD3 levels are closely associated with coronary artery disease |
Q36042601 | TGF-β and Smad3 modulate PI3K/Akt signaling pathway in vascular smooth muscle cells |
Q34798852 | TGF-β and restenosis revisited: a Smad link |
Q34007727 | TGF-β/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A. |
Q21090638 | TGF-β/Smad3 stimulates stem cell/developmental gene expression and vascular smooth muscle cell de-differentiation |
Q38205776 | The role of Notch pathway in cardiovascular diseases. |
Q36079195 | The role of atorvastatin on the restenosis process post-PTA in a diabetic rabbit model |
Q48222456 | Time-dependent trends in cardiovascular adverse events during follow-up after carotid or iliofemoral endarterectomy |
Q37882523 | Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects |
Q42014388 | Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinases pathways |